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Purpose: To investigate the combined effect of olfactory ensheathing cell (OEC) transplantation and recombinant human
glial cell line-derived neurotrophic factor (rhGDNF) intravitreal injection on optic nerve functional recovery following
incomplete injury in adult rats.
Methods: The optic nerves of adult rats were crushed by forceps and then GDNF was injected into vitreous cavity, OECs
transplanted into injured optic nerve, or GDNF vitreous injection combined with OECs transplantation, and balanced salt
solution was injected into vitreous cavity of control group rats respectively. Flash visual evoked potential (F-VEP) was
performed on the injured eye immediately after injury and at 1, 2, 4, and 8 weeks after injury.
Results: The F-VEP waveforms were almost silent immediately after the optic nerve injury. The latency of the F-VEP
(LP1) recovered nearly to the normal value 1 week after injury in the treatment groups. The amplitude recovered more
slowly. It recovered more obviously and rapidly in the rhGDNF combined with OEC group. At 8 weeks after injury, the
amplitude was restored to 64.5% of the pre-injury level in the control group and to 91.8% in the GDNF+OEC treatment
group. Wheat germ agglutinin (WGA) labeling showed retinal ganglion cell (RGC) axon regeneration and prolongation
in the combined group, and the regenerated axons extended across the traumatized area and reached the distal end of the
injured optic nerve.
Conclusions: The combination of OEC transplantation and rhGDNF intravitreal injection will be more effective in
promoting the recovery of visual function after incomplete injury of the optic nerve in adult rats.
The optic nerve is part of the central nervous system and
cannot easily regenerate after injury. Incomplete optic nerve
injury occurs frequently [1,2] and it is thought that improving
the microenvironment by means such as cell transplantation
and administration of exogenous neurotrophic factors may
promote the regeneration of injured optic nerve fibers [3,4].
Various therapeutic methods may act on the nervous tissue
differently, and the combination of two methods may exert a
better effect than one method alone. Therefore, combining
multiple therapeutic methods may become the main way of
treating optic nerve injuries.
Olfactory ensheathing cells (OECs) are unique glial cells
that are responsible for the regeneration of olfactory axons
throughout  the  life  of  adult  mammals.  They  exist  in  the
olfactory mucosa, olfactory nerve, and the two superficial
layers of the olfactory bulb (the olfactory nerve fiber layer and
olfactory glomerulus layer). Olfactory ensheathing cells have
the same characteristics as astrocytes in the central nervous
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system and Schwann cells in the peripheral nervous system;
however, they differ from other types of glial cells in terms of
development, morphology, and immunohistochemistry [5,6].
It has been shown that OECs secrete neurotrophic factors
(NTFs), including nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3/4 (NT-3/4), and
ciliary neurotrophic factor (CNTF). These NTFs are related
to  the  survival,  differentiation,  growth,  and  maturation  of
olfactory neurons, and they may serve as the major factors for
promoting  nerve  growth,  regeneration,  and  repair  [7,8].
Following injury to the nervous system, glial scars impede the
regeneration  and  elongation  of  nerve  fibers.  Olfactory
ensheathing cells may penetrate glial scars and establish a glial
tunnel, thus promoting nerve regeneration and repair [9,10].
Olfactory ensheathing cells also have the same characteristics
as oligodendrocytes and neurons. It has been demonstrated
that OECs promote the regeneration of central nerves and the
spinal cord [11-13]. Therefore, OECs have attracted much
attention from researchers in recent years and have been used
in cell transplantation to treat central nervous system injuries.
It has been shown that OECs implanted into an injured central
nervous  system  formed  cellular  bridges  that  guided  axon
growth and prolongation [6,11].
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2903Glial cell line-derived neurotrophic factor (GDNF) is one
of the most potent neurotrophic factors that promote in vitro
neuronal growth. It not only prevents neuron apoptosis during
development,  but  also  promotes  the  survival  of  cortical
neurons following nerve injury [14]. Glial cell line-derived
neurotrophic factor has been found to protect spinal motor
neurons  and  peripheral  nerves  significantly  in  in  vitro
experiments  and  after  sciatic  nerve  transection  [15,16].
Therefore,  we  postulated  that  GDNF  is  important  in  the
regeneration and functional recovery of the optic nerve after
injury.  Recombinant  human  glial  cell  line-derived
neurotrophic  factor  (rhGDNF)  is  a  30  kDa  homodimer
consisting of two disulfide-linked 134 amino acid subunits. It
is produced from recombinant DNA expressed in E. coli.
Recombinant  human  glial  cell  line-derived  neurotrophic
factor can be obtained commercially and is suitable for future
clinical use. In the present study, we injected rhGDNF into a
vitreous body, cultured OECs, and transplanted them into
injured optic nerves, then performed an intravitreous injection
of  wheat  germ  agglutinin  (WGA)  to  anterogradely  label
retinal ganglion cells (RGCs), and used flash visual evoked
potential (F-VEP) to assess the effect of OEC transplantation
and GDNF intravitreal injection on the functional recovery of
optic nerves after incomplete injury.
METHODS
Culturing,  purification,  and  transplantation  of  OECs:  As
described  previously  [17],  the  olfactory  nerve  layer  and
olfactory bulb granular layer were obtained from 60-day-old
male  Sprague-Dawley  rats  (SD  rats;  provided  by  the
Experimental Animal Center of the Third Military Medical
University, Chongqing China), and were digested with 0.1%
trypsin. The digests were added to Dulbecco's Modified Eagle
Medium Nutrient Mixture F-12 (DMEM/F-12; Gibco, Grand
Island, NY) containing 10% fetal bovine serum (FBS; Gibco)
and  were  mechanically  dissociated  into  a  single  cell
suspension. The cells were then inoculated into glass flasks
not covered with gelatin. After the addition of DMEM/F-12
containing  FBS,  the  flasks  were  cultured  for  12  h  in  air
containing 5% CO2 at 37 °C. The culture supernatants along
with non-adhered cells were then transferred into another
glass flask not covered with gelatin, followed by another 12
h of culturing. After that, the cell density was adjusted to
1×106/ml  and  the  cells  were  implanted  into  6-well  plates
pretreated  with  polylysine,  followed  by  another  week  of
culturing.  The  cells  were  treated  with
Arabinofuranosylcytosine  (final  concentration,  10−5  mol/l
Ara-C; Invitrogen, Carlsbad, CA) for 48 h, washed, and added
to 2 μmol/l forskolin and 20 μg/ml bovine pituitary extract
(BPE; Sigma, Carlsbad, CA). After approximately 10 days of
culturing,  the  cells  were  transplanted  and  identified  by
immunofluorescence staining with anti-nerve growth factor
receptor  (NGFR-p75)  antibody  (diluted  1:50;  Sigma,)  to
determine  cell  purity.  Low  Hoechst  concentrations  and
appropriate durations of treatment can result in fluorescence
labeling of cell nuclei without influencing cell viability. Most
OECs  used  for  transplantation  were  obtained  by  direct
digestion (final concentration, 1×107/ml). Some OECs were
subjected  to  nucleus  labeling  with  10  μg/ml  dibenzimide
(Hoechst 33342; Sigma) through 30 min incubation at 37 °C.
After labeling, the cells were washed twice with serum-free
DMEM/F-12.  The  cell  density  was  adjusted  to  1×107/ml
before cell transplantation.
Animal  model  preparation  and  groups:  All  procedures
accorded with the Association for Research in Vision and
Ophthalmology  Resolution  guidelines.  The  rats  were
maintained on food and water with a 12 h:12 h light-dark cycle
(7:00  AM–7:00  PM).  All  operations  were  performed  on
animals  anesthetized  with  intraperitoneal  injections  of
ketamine  (80  mg/kg)  and  xylazine  (8  mg/kg).  Before  all
operations,  0.4%  oxybuprocaine  hydrochloride  (Alcon
Laboratories, Fort Worth, TX) was applied to the eyes for
superficial  anesthesia  and  antiseptic  eye  drops  (0.3%
tobramycin, Alcon Laboratories, Inc.) were used to prevent
post-treatment  infection.  All  animals  were  humanely
euthanized  with  an  overdose  of  anesthesia.  After
anesthetization, the rats were placed in the lateral decubitus
position.  Under  microscopy,  the  lateral  canthus  and  the
temporal  ocular  conjunctiva  were  cut  open  and
subconjunctival  and  postbulbar  tissues  were  isolated  to
expose the optic nerve. The optic nerve was clamped for 10 s
using an atraumatic vascular clamp 1.5 mm behind the eyeball
to cause moderate optic nerve injury (refer to the models of
various degrees of incomplete injury to the rat optic nerve
established  previously).  The  ocular  artery  should  not  be
injured.  Antibiotic  eye  drops  and  ointments  were  used
postoperatively. Only one eye (the right eye) was operated on.
The  blood  supply  of  the  rat  ocular  fundus  was  observed
postoperatively  and  rats  without  fundus  ischemia  were
included in the following experiments.
Eighty adult male SD rats (weighing 240–260 g) were
randomized into four groups (20 animals in each group). The
vitreous cavities of one group were injected with rhGDNF
(GDNF group). Another group was transplanted with OECs
in the injured optic nerve (OEC group). A third group was
treated with an rhGDNF injection and OEC transplantation
(GDNF+OEC  group).  In  addition,  because  a  previous
experiment showed a balanced salt solution injection at the
traumatized area was ineffective, a balanced salt solution was
injected into the vitreous cavities of the fourth group (Control
group). For each group, treatment occurred at five time points,
i.e., immediately after injury and at 1, 2, 4, and 8 weeks after
injury.  For  each  group  of  20  animals,  five  animals  were
assessed and then sacrificed at weeks 1, 2, 4, and 8 after injury.
Intravitreal injection: A sterile microinjector was introduced
obliquely  backward  and  downward  at  the  ambitus  of  the
eyeball  (3  mm  from  the  sclerocorneal  limbus)  for  the
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2904anesthetized  rats.  The  needle  tip  was  monitored  directly
through the pupil to avoid injuring the lens and 2 μl (2 μg)
rhGDNF (G2781; Promega Corporation, Madison, WI) was
injected into the vitreous cavity.
Transplantation of OECs: After the optic nerve was exposed,
2 μl of an OEC suspension (cell concentration, 1×107/ml) was
transplanted into the proximal end 1 mm away from the injury
site using the microinjector. The tip of the injector pricked the
myelin sheath of the optic nerve and was inched toward the
injury site for 0.5 mm. The OEC suspension was then injected
slowly for more than 1 min and the needle was left in place
for 2–3 min. The time points for injection were immediately
after injury and 1, 2, 4, and 8 weeks after injury. The rhGDNF
was prepared as described previously [15]. The purity of the
rhGDNF was 96%.
Figure 1. Olfactory ensheathing cells culture, purification, and immunofluorescence staining. A: OECs cultured for 8 days, B: OECs cultured
for 14 days C: cultured for 8 days, D: cultured for 14 days OECs with immuofluorescence staining. NGFR-p75 staining for OEC (red);
fibronectin staining for ONF (green). The scale bar is 20 μm.
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2905Visual electrophysiology investigation: Flash visual evoked
potential (F-VEP) was performed on the eyes before injury,
immediately after injury, and before sacrifice. The rats were
anesthetized  and  immobilized  on  a  special  supporter.  A
ROLAND  RETIport  (Roland  Consult,  Brandenburg,
Germany) visual electrophysiology system with silver needle
electrodes was used. The recording electrode was inserted into
the  subperiosteum  of  the  rat  occipital  tuberosity  and  the
reference  electrode  was  inserted  subcutaneously  at  the
midpoint between the two eyes. The ground electrode was
inserted subcutaneously at the ear tip. Full visual field white
flash stimulation was applied, with a flash intensity of 3. 93cd/
m2s  without  background  light  and  with  a  stimulation
frequency of 2 Hz, a band pass width of 1–100 Hz, and at
20,000×  magnification.  The  time  for  each  sampling  was
250 ms and the waveform was superimposed 50 times. Each
rat was recorded three times with an interval of 10 min. The
parameters  observed  were  F-VEP  latency  LP1  (P1  wave
response time, ms) and amplitude AP1-N2 (delta between P1
wave trough and N2 wave peak, μV). Three measurements
were averaged for each parameter.
Anterograde labeling with WGA for RGCs axons: Intravitreal
injection of WGA (Sigma) was performed to anterogradely
label RGC axons as described by Weibel [18]. The procedure
was as follows: After anesthesia, 5 μl 2.5% WGA was injected
into the vitreous bodies of the rats. Then at each experimental
point, the rats were perfused with 4% paraform and the optic
nerve was taken out and fixed in 4% paraform containing 20%
sucrose at 4 °C for 10 h. The fixed optic nerve was then
embedded by Optimal Cutting Temperature compound (OCT;
SAKURA Inc., New York, NY) and cut into 10 μm sections.
The  primary  antibody  (containing  3%  BSA,  0.  3%
TritonX-100, and 0.01 mol/l PBS) goat-anti WGA (1:200)
was added and incubated for one night at 4 °C, then washed
three times. Secondary antibody rabbit-anti-goat fluorescein
isothiocyanate (FITC; 1:64) was added and incubated for 2 h
at 37 °C.
Statistical analysis: Data were presented as mean±standard
error of the mean (SEM). Statistical analysis was made using
either a Student’s two-tailed t-test or ANOVA with SPSS11.0
software. Differences were considered to be significant at
p<0.05 and statistically very significant at p<0. 01.
RESULTS
Detecting  the  purity  of  OECs:  The  purified  OECs  were
cultured for 6 days. Most cells displayed short processes with
a three-dimensional cell body and good refractiveness. The
cells  were  identified  as  OECs  using  immunofluorescence
staining (Figure 1). After about 10 days of culturing, the
purified cells were found to have long and thin processes, and
the  cells  were  in  a  bipolar  or  multipolar  shape  and  were
interconnected in a network. There were a small number of
background cells, which had large cell bodies, poor three-
dimensional sense, an irregular shape, and they formed a
gossamer structure. These were fibroblasts. Based on purity
calculation  (the  ratio  of  the  number  of
immunohistochemically stained cells to the number of all
cells), the cell purity was above 90%.
Animals  with  intravitreal  injection  and/or  OEC
transplantation: Five rats from each group were examined at
each time point (including immediately after injury and 1, 2,
4, and 8 weeks after injury). The rats were sacrificed after VEP
investigation  at  each  time  point  except  immediately  after
injury; therefore, a total of 80 rats were used in this study. All
the rats in the GDNF group that received intravitreal rhGDNF
injections and Control group rats successfully endured the
experiment. One rat in the OEC group died two days after
OEC transplantation. One rat in the GDNF+OEC group died
one day after the animal model preparation and treatment
operation, and one rat died two days after F-VEP investigation
at  4th  week  time  point.  Thus,  in  this  experiment,  96.3%
(77/80)  of  the  rats  survived  the  optic  nerve  injury  model
preparation, intravitreal injections, and cell transplantation.
F-VEP  investigation:  The  F-VEP  investigations  were
performed successfully using a ROLAND RETIport visual
electrophysiology system and the waveforms could be clearly
distinguished (Figure 2A). Immediately after the optic nerve
injury, the F-VEP waveforms were almost silent, the latency
was obviously prolonged, and the amplitude was significantly
reduced (Figure 2B). At 1 week after injury, the latency was
almost restored to the pre-injury level in the treatment groups,
Figure 2. Representative waveforms of flash visual evoked potential
(F-VEP) in rats. A: Each peak of F-VEP could be distinguished
clearly  in  normal  rats,  including  N1,  P1,  and  N2  waves.  B:
Immediately  after  the  optic  nerve  injury,  the  F-VEP  waveform
appeared silent and peaks could not be identified. C: Four weeks after
OEC+GDNF treatment, F-VEP latency obviously decreased and
amplitude increased significantly in rats with injured optic nerves.
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2906especially for the GDNF+OECs group (p<0.01 versus Control
and  p<0.05  versus  GDNF  groups;  Figure  2C);  it  then
decreased gradually (Figure 3). The amplitude was restored
more slowly, and at 1–2 weeks after injury, the amplitude did
not differ significantly between the treatment groups and the
Control group (p>0. 05). At 4 weeks after injury, the OEC
group differed significantly from the Control group (p<0. 05),
and the GDNF+OECs group differed from the Control group
very significantly (Figure 4). At 8 weeks after injury, the
amplitude was restored to 64.5% of the pre-injury level in the
Control group, to 77.1% in the GDNF treatment group, to
77.6% in the OEC treatment group, and to 91.8% in the GDNF
+OECs treatment group.
WGA  labeling  for  RGC  axons  regeneration:  The  WGA
labeled  axons  of  normal  optic  nerves  were  longitudinally
arrayed and appeared even and intensive. After the optic nerve
injury, the ends of axons accumulated and became twisted,
even appearing backward, and seldom entered the traumatized
area (Figure 5A). After being injured for 1 week, rich WGA-
labeled  axons  were  displayed  at  the  proximal  end  of  the
traumatized  area  and  the  density  of  WGA-labeled  axons
decreased significantly at the distal end about 500 μm away
from the traumatic point; a few axons entered the distal end
(Figure 5B). However, 1 week after injury, the ends of the
axons in the GDNF+OEC group were more extensive and
Figure 3. Latency (LP1) of flash visual evoked potential (F-VEP)
before and after optic nerve injury. The LP1 was obviously delayed
immediately after the optic nerve injury and was then rapidly restored
1 week after the injury, especially in the OEC+GDNF group. At 8
weeks, the LP1 of the OEC+GDNF group was almost restored to the
normal value, but it was still obviously delayed in the Control, OEC,
and GDNF groups. Data were shown as mean±SD (n=5). #: p<0.01
versus OEC+GDNF group; *: p<0.05 versus OEC+GDNF group.
outspread (Figure 5C). At 2 weeks, some axons entered the
traumatized area, especially the axons adjoined to the optic
nerve sheath (Figure 5D). At 4 weeks (Figure 5E) and 8 weeks
(Figure 5F) after injury, the WGA-labeled nerve fibers in the
GDNF+OEC  group  were  obviously  prolongated  and
displayed  abundant  regenerated  axons.  Eight  weeks  after
injury, some nerve fibers in the OEC group degenerated and
a  few  new  fibers  regenerated  and  extended  across  the
traumatized area and reached the distal end. However, the
regenerated axons appeared significantly less than in the OEC
+GDNF group (Figure 5G).
DISCUSSION
Optic nerve repair has long been the focus of research for
many scholars. Breakthroughs in this field will shed light on
central nerve repair after injury and regeneration. The optic
nerve consists of RGC axons. Therefore, visual recovery is
closely associated with the degree of RGC injury, the status
of material transport and the synthesis of axoplasm, and the
ability to self-repair and regenerate [19,20]. The F-VEP can
objectively reflect the degree of optic nerve injury and nerve
conduction; hence, it can be used to assess retina-visual cortex
conduction. The F-VEP latency reflects the function of nerve
conduction  and  axon  myelin  sheath  integrity,  and  F-VEP
amplitude reflects the receptive function of the macula lutea
Figure 4. Amplitude (AP1-N2) of flash visual evoked potential (F-
VEP) before and after optic nerve injury. The AP1-N2 obviously
decreased immediately after the optic nerve injury, and was then
restored very slowly. At 2 weeks, the AP1-N2 of the OEC+GDNF
group were obviously restored compared with the Control, OEC, and
GDNF groups. At 4 weeks and 8 weeks after injury, the AP1-N2 of
the OEC+GDNF, OEC, and GDNF groups increased significantly
compared to the Control group. #: p<0.01 versus Control group; *:
p<0.05 versus Control group. Data were shown as mean±SD (n=5).
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2907Figure 5. The longitudinal sections of RGC axons were labeled with wheat germ agglutinin (WGA) for axonal regeneration. A: After optic
nerve injury, the ends of axons became accumulated and twisted. B: One week after injured rich WGA-labeled axons were visualized at the
proximal end of the traumatized area, a few axons entered the distal end. C: One week after injury, the ends of the axons in the OEC+GDNF
group were more extense and outspread. D: Two weeks after injury, some axons entered the traumatized area and reached the distal end of
the traumatized area. E: Four weeks and F, 8 weeks after injury, WGA-labeled nerve fibers in the OEC+GDNF group were obviously
prolongated and displayed abundant regenerated axons. At these time points the figure showed regenerated axons tangled and fluorescence
accumulated there. G: Eight weeks after injury, a few new fibers regenerated in the OEC group and extended across the traumatized area to
reach the distal end; however, the regenerated axons appeared significantly less than in the OEC+GDNF group. H: Negative control for WGA-
labeled optic nerve axons. All images: left is the proximal end and right is distal end of optic nerve injured point. The scale bar is 100 μm.
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2908and the number of synaptic contacts between intact axons and
their targets [21]. In the present study, we observed a nearly
silent pattern of F-VEP waveforms immediately after injury,
indicating a shock to visual function, which may be caused by
increased  pressure  in  the  nerve  tract,  axon  hypoxia,  and
transient blockage of nerve conduction due to nerve edema
[22]. At 1 week after optic nerve injury, F-VEP latency was
almost restored to the pre-injury level in the experimental
groups, especially in the combined treatment group. The rapid
recovery of the latency suggests that visual stimulation can
cause cortical responses within a short time period if there are
a certain number of intact optic nerve axon myelin sheaths and
normal synaptic contacts in the target tissues after relief from
the shock. Sabel [23] demonstrated that light perception can
be restored if approximately 10% of RGCs had contact with
target tissues. However, in clinical settings, vision can be
partially restored in some patients with optic nerve injury
without treatment [24]. This suggests that the optic nerve can
repair itself to a certain extent after incomplete injury. At 4–
8 weeks after injury, 60%–80% of F-VEP amplitude was
restored to normal values, even to above 90% of the pre-injury
level in the treatment group with subsidence of axonal edema,
restoration of axoplasmic transport, and partial recovery of the
axon regenerative ability. The recovery of F-VEP amplitude
was significantly better in the treatment group than the Control
group, suggesting that combined treatment promotes visual
functional recovery. Incomplete and slow recovery of F-VEP
amplitude may be related to the limited regenerative ability of
the  optic  nerve  after  injury  and  progressive  nerve  tissue
degeneration. Therefore, we believe F-VEP amplitude is a
better parameter than F-VEP latency to reflect visual function
in animal studies.
Glial cell line-derived neurotrophic factor has multiple
biologic effects and is thought to play dual roles in neuronal
survival and axonal regeneration [6]. Continuous injections of
rhGDNF  into  the  vitreous  cavity  may  work  by  replacing
neurotrophic  factors  or  promoting  the  transportation  of
neurotrophic factors, enhancing the resistance of RGCs to
primary injury (and particularly to secondary injury), and
mitigating  the  secondary  degeneration  and  apoptosis  of
neurons with minor injury or without injury, thus protecting
RGCs  and  slowing  down  nerve  tissue  degeneration  and
preserving as many nerve fibers as possible. It may also work
by  enhancing  nerve  regeneration  [25]  and  promoting  the
prolongation of regenerating axons after incomplete injury. It
may also promote the recovery of axoplasmic transportation,
enhancing synthesis and metabolism in nerve cells, regulating
nerve  nutrition,  mitigating  tissue  edema,  relieving  topical
pressure, and improving the internal environment of nerve
tissues, thus helping the functional recovery of impaired nerve
fibers.
In  previous  study,  sole  GDNF  exhibited  certain
protective effect on neurons after spinal injury, but it did not
promote axon regeneration significantly in this study. This
may be explained as follows. First, GDNF promotes axonal
regeneration,  but  regenerated  axons  cannot  grow  into  the
injured  spine  and  scars.  Second,  GDNF  is  metabolized
quickly after it is injected into the body. Olfactory ensheathing
cells are cells that exist in the transitional zone of the central
and peripheral nervous systems and are functionally active.
They  have  become  one  of  the  preferred  cell  types  in  the
treatment of spinal injuries in recent years. The present study
demonstrated that central axons were regenerated after injury
only in the two groups treated with OECs. In the present study,
we found for the first time that axonal regeneration did not
greatly differ between the GDNF and Control groups, but the
combination of GDNF and OECs promoted the OEC repair
of spinal injuries, suggesting the synergism of GDNF and
OECs. Such synergism can be explained by the following
mechanisms: (1) During the late stage of injury, glial scars
secrete  large  amounts  of  inhibitory  factors  and  act  as  a
physical barrier to axon growth. As a result, GDNF cannot
promote regenerating axons to penetrate glial scars. The OECs
may serve as a cell bridge, guiding nerve fibers to grow and
penetrate glial scars. Hence, OECs exhibited a synergistic
action with GDNF in promoting axonal regeneration. (2) Glial
cell line-derived neurotrophic factor may protect transplanted
OECs and may even promote the proliferation of OECs, thus
enhancing the action of OECs.
Conclusion: We propose that OEC transplantation and
rhGDNF injection can promote the recovery of visual function
after the incomplete injury of the optic nerve in adult rats and
that  a  combination  of  OECs  and  rhGDNF  will  be  most
effective. The present study sheds light on the regeneration
and repair of the optic nerve and even central nerves following
injury  and  provides  a  new  treatment  option  with  certain
clinical significance.
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